Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.63 |
| ▸ | ERN1 | O75460 | 4/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | PRKDC | P78527 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.44 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.44 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.43 |
| ▸ | TYR | P14679 | 1/20 | 0.43 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.43 |
| ▸ | TLR2 | O60603 | 1/20 | 0.43 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30178662 | 1.00 | ALDH1A1 (0.63) | ALDH1A1ERN1TSHRKDM4ETDP1 | |
| SCHEMBL2636617 | 0.90 | ALDH1A1 (0.53) | ALDH1A1ERN1TSHRKDM4ETDP1 | |
| SCHEMBL6093571 | 0.85 | ERN1 (0.46) | ALDH1A1ERN1TSHRKDM4ETDP1 | |
| SCHEMBL153974 | 0.84 | ERN1 (0.58) | ALDH1A1ERN1TSHRKDM4ETDP1 | |
| SCHEMBL29890082 | 0.84 | ERN1 (0.58) | ALDH1A1ERN1TSHRKDM4ETDP1 | |
| SCHEMBL28988651 | 0.83 | CYP1A2 (0.47) | ALDH1A1ERN1TSHRKDM4ETDP1 | |
| SCHEMBL17426244 | 0.82 | ERN1 (0.56) | ALDH1A1ERN1TSHRKDM4ETDP1 | |
| SCHEMBL21352066 | 0.82 | TUBB4A (0.46) | ALDH1A1ERN1KDM4ETDP1L3MBTL1 | |
| SCHEMBL27890878 | 0.82 | ERN1 (0.48) | ALDH1A1ERN1TDP1PRKDCL3MBTL1 | |
| SCHEMBL46203 | 0.81 | ALDH1A1 (0.55) | ALDH1A1ERN1PRKDCL3MBTL1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 550 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118027327-B | COFs material capable of improving carrier separation efficiency and preparation method and application thereof | 生态环境部南京环境科学研究所 | 2024-10-25 | — | — | CN | claimed |
| CN-118027327-A | COFs material capable of improving carrier separation efficiency and preparation method and application thereof | 生态环境部南京环境科学研究所 | 2024-05-14 | — | — | CN | claimed |
| CN-117945947-A | Synthesis method of 2-methoxy-4-cyanobenzaldehyde | 江西凯信生物医药有限公司 | 2024-04-30 | — | — | CN | claimed |
| CN-117924273-A | Preparation method of non-neridrone bulk drug | 江苏德源药业股份有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-117304067-A | Synthesis method of non-nefardone intermediate 4-cyano-2-methoxybenzaldehyde | 南京工业大学 | 2023-12-29 | — | — | CN | claimed |
| CN-116082334-A | Preparation method of non-neridrone and intermediate thereof | 上海新礼泰药业有限公司 | 2023-05-09 | — | — | CN | claimed |
| CN-116041347-A | Preparation method of non-nereirenone intermediate | 上海新礼泰药业有限公司 | 2023-05-02 | — | — | CN | claimed |
| CN-111233908-A | Benzoxaborol-1-ol compound and preparation method and application thereof | 南京农业大学 | 2020-06-05 | — | — | CN | claimed |
| EP-2593419-A1 | PROCESSES FOR PRODUCING 4-BROMO-2-METHOXYBENZALDEHYDE | Albemarle Corporation (US) | 2013-05-22 | — | — | EP | claimed |
| US-20130090498-A1 | PROCESSES FOR PRODUCING 4-BROMO-2-METHOXYBENZALDEHYDE | ALBEMARLE CORPORATION (US) | 2013-04-11 | — | — | US | claimed |
| WO-2012009173-A1 | PROCESSES FOR PRODUCING 4-BROMO-2-METHOXYBENZALDEHYDE | ALBEMARLE CORPORATION (US) | 2012-01-19 | — | — | WO | claimed |
| US-20260124191-A1 | HISTONE DEACETYLASE INHIBITOR AND USES THEREOF | NANJING HONGSHUN PHARMACEUTICAL TECHNOLOGY CO., LTD (CN) | 2026-05-07 | — | — | US | disclosed |
| EP-4519384-B1 | PHOTOACTIVATABLE COMPOUNDS AND USES THEREOF | PROMEGA CORP (US) | 2026-04-29 | — | — | EP | disclosed |
| EP-4725940-A1 | HISTONE DEACETYLASE INHIBITOR AND USE | Nanjing Hongshun Pharmaceutical Technology Co., Ltd (CN) | 2026-04-15 | — | — | EP | disclosed |
| EP-4716685-A1 | IMIDAZO[4,5-C]PYRIDINE COMPOUNDS FOR THE TREATMENT OF CANCER | F. Hoffmann-La Roche AG (CH) | 2026-04-01 | — | — | EP | disclosed |
| WO-2002089738-A2 | PROTEOMIMETIC COMPOUNDS AND METHODS | YALE UNIVERSITY (US) | 2002-11-14 | — | — | WO | disclosed |
| EP-1244446-A1 | THROMBOPOIETIN MIMETICS | SmithKline Beecham Corporation (US) | 2002-10-02 | — | — | EP | disclosed |
| WO-2001039773-A1 | THROMBOPOIETIN MIMETICS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-06-07 | — | — | WO | disclosed |
| EP-0417760-A2 | Phenylalkanoyl substituted imidazo[4,5-c] pyridines | G.D. Searle & Co. (US) | 1991-03-20 | — | — | EP | disclosed |
| US-4988707-A | Platelet activating factor, antiinflammatory agents, cardiovascular disorders and treatment of asthma | G. D. SEARLE & CO. (US) | 1991-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130090498-A1 | PROCESSES FOR PRODUCING 4-BROMO-2-METHOXYBENZALDEHYDE | KCNMB4, KCNB1, KCNMB1 | ALDH1A1 761/4885ERN1 2733/4885TSHR 3796/4885 |
| US-20260124191-A1 | HISTONE DEACETYLASE INHIBITOR AND USES THEREOF | HDAC1, HDAC3, HDAC2 | ALDH1A1 2329/4885ERN1 1705/4885TSHR 3098/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.